|
Title: |
Trends in Cox-2 Inhibitor Research |
Search Result:
| Edited by: |
Maynard J Howardell |
| ISBN10-13: |
1600212220 : 9781600212222 |
| Illustrations: |
tables & charts |
| Format: |
Hardback |
| Size: |
180x260mm |
| Pages: |
169 |
| Weight: |
.602 Kg. |
| Published: |
Nova Science Publishers, Inc (US) - May 2006 |
| List Price: |
154.99 Pounds Sterling |
| Availability: |
In Stock
Qty Available: 1 |
| Subjects: |
Medical research : Pharmacology |
| Cox-2 Inhibitors are newly developed drugs for inflammation that selectively block the Cox-2 enzyme. Blocking this enzyme impedes the production of the chemical messengers (prostaglandins) that cause the pain and swelling of arthritis inflammation. Cox-2 inhibitors are a new class of non-steroidal anti-inflammatory drugs (NSAIDS). Because they selectively block the Cox-2 enzyme and not the Cox-1 enzyme, these drugs are uniquely different from traditional NSAIDS. This book explores new research in the field. |
| Table of Contents: |
| Preface; NSAIDs in Animal Models of Alzheimer’s Disease; Relevance of COX-2 Inhibitors in Alzheimer’s Disease; COX.1-COX.2 Simultaneous Inhibitory Mechanism in Gastric Injury and COX.2-COX.3 in Small Intestine Injury; Effects of Cox-2 Inhibitors on Brain Diseases; Cyclooxygenase-2 Overexpression and the Chemopreventive and Therapeutic Uses of Cyclooxygenase Inhibitors in Lung Cancer; Safety Monitoring of Celecoxib and Rofecoxib in the New Zealand Intensive Medicines Monitoring Programme; The Effect of COX-2 Inhibitor in Osteoarthritic Chondrocytes; Index. |
Item added to 
.png "Click here for catalogues")
